OR WAIT null SECS
October 05, 2021
Three products, including Pfizer’s smoking cessation product Chantix, have been removed because generics are now available.
October 04, 2021
Aetna, Cigna and UnitedHealthcare are enhancing their Medicare pharmacy benefits, including offering insulin for a copay of no more than $35 for a 30-day supply.
October 01, 2021
Given together, bamlanivimab and etesevimab have an emergency use authorization from the FDA to both treat COVID-19 and prevent infection in those who have been exposed.
Effective Oct. 1, 2021, Aetna has added several cancer drugs to its formulary and has updated exclusions and nonpreferred products.
Comprehensive medication management aided by AI clinical decision support can result in a large return on investment in a high-risk population. In this study, every dollar that was invested resulted in $12 in savings or cost avoidance.
Trudhesa was approved in September to treat migraine.
September 30, 2021
The enzyme replacement therapy treats Pompe disease, a rare genetic disorder that affects children.
September 28, 2021
Effective Jan. 1 2022, the move brings the price to 2008 levels.
September 27, 2021
Prices paid by Veterans Affairs were the lowest and were 50% to 60% below list prices.
September 24, 2021
Amgen’s Biosimilar Trend Report finds that biosimilars have been introduced at a price that is generally 15% to 37% lower than the reference product.
